CompletedPhase 4

Oral Progesterone for Prevention of Miscarriage in Threatened Abortion

Thailand100 participantsStarted 2021-08-01

Plain-language summary

This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * singleton pregnancy with gestational age 6 - 20 weeks * threatened abortion * confirmed intrauterine pregnancy with a viable fetus by ultrasound Exclusion Criteria: * history of recurrent miscarriage * having endocervical polyp * having infection such as pneumonia, pyelonephritis, septicemia * having autoimmune diseases such as systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis * having cancer * having coagulation defect * allergy to dydrogesterone

What they're measuring

continue pregnancy more than 20 weeks gestation

Timeframe: at 20 weeks gestation

Trial details

NCT IDNCT04788108

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-08-31

View on ClinicalTrials.gov More Threatened Abortion trials